Back to Search
Start Over
Deconstructing behavioral neuropharmacology with cellular specificity
- Source :
- Science. 356
- Publication Year :
- 2017
- Publisher :
- American Association for the Advancement of Science (AAAS), 2017.
-
Abstract
- A tailored look at behavioral pharmacology It is important to understand how animal behavior is mediated by molecular, cellular, and circuit components of the brain. However, it has been difficult to link the activity of specific molecules in defined cells to behavioral roles. Shields et al. developed an approach to deconstruct behavioral neuropharmacology with cellular specificity. The technique, termed DART (drugs acutely restricted by tethering), uses enzymatic capture to restrict standard drugs to the surface of genetically specified cells without prior modification of the native pharmacological target. The method provides cell-type specificity, endogenous-protein specificity, acute onset, and utility in behaving animals. This enables the activity of specific molecules in defined circuit elements to be causally linked to behavior. Science , this issue p. eaaj2161
- Subjects :
- 0301 basic medicine
Long-Term Potentiation
Nanotechnology
Muscarinic Antagonists
Biology
Mice
03 medical and health sciences
0302 clinical medicine
Acute onset
Quinoxalines
Animals
Animal behavior
Neuropharmacology
Neurons
Multidisciplinary
Behavior, Animal
Parkinson Disease
Corpus Striatum
Optogenetics
Disease Models, Animal
030104 developmental biology
Receptors, Glutamate
Drug Design
Excitatory Amino Acid Antagonists
Neuroscience
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 10959203 and 00368075
- Volume :
- 356
- Database :
- OpenAIRE
- Journal :
- Science
- Accession number :
- edsair.doi.dedup.....efbc661168013ce14517b8e843c0aa33
- Full Text :
- https://doi.org/10.1126/science.aaj2161